Loading chat...

IN SB0157

Bill

Official Source

Status

Engrossed

1/27/2026

Primary Sponsor

Mike Bohacek

Click for details

Origin

Senate

2026 Regular Session

AI Summary

  • Pharmacists and pharmacies must disclose the national average drug acquisition cost (NADAC) for generic drugs on written materials provided to customers at the point of sale

  • Exempts hospitals licensed under IC 16-21-2, federally qualified health centers, and health facilities licensed under IC 16-28 from the disclosure requirement

  • Maintains existing requirement that health plans provide NADAC information for generic drugs to plan sponsors

  • Effective date: July 1, 2026

  • Passed Senate Committee on Insurance and Financial Institutions with unanimous 9-0 vote

Legislative Description

Disclosures related to prescription drugs.

Last Action

First reading: referred to Committee on Public Health

1/28/2026

Committee Referrals

Public Health1/28/2026
Insurance & Financial Institutions1/5/2026

Full Bill Text

No bill text available